AKITA is a brand developed by Finnadvance Ltd., a Finnish biotechnology company that specializes in scalable organ-on-chip platforms. Their products and services aim to accelerate drug development and research by providing highly accurate biological modeling. Unlike conventional in-vitro methods, AKITA's platforms recreate specific microphysiological conditions that enable cells to function as they would in the human body.

This unique approach produces more reliable results and allows for co-culturing multiple cell lines simultaneously. AKITA's mission is to create a better life for every human being, regardless of race, gender, or socioeconomic status, by enabling the development of innovative therapies and delivering more effective drugs. The brand is dedicated to quality and complies with industry regulations while continuously updating and evaluating their quality strategy.

With a team of highly experienced professionals, AKITA is at the forefront of biotechnological advancements. Contact their experts to discover how AKITA can supercharge your research and propel medical innovation forward